Can we diagnose acute rheumatic fever early to maximize the success of secondary prophylaxis in rheumatic heart valve disease?

Cardiovasc Res. 2022 Jul 20;118(9):e62-e65. doi: 10.1093/cvr/cvac071.

Livia S A Passos¹, Victor Nizet², Robert A Levine³, Elena Aikawa^{1

4}

¹ Center for Excellence in Vascular Biology, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
² Department of Pediatrics and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.
³ Cardiac Ultrasound Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
⁴ Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

No abstract available

Keywords: autoimmunity; heart valves; rheumatic fever; rheumatic heart valve disease; valvular damage.

Publication types